Healthcare provider profile · identity verified

Keith L Papendick, MD

Family Practice · BATTLE CREEK, MI · NPI 1700992484

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	355	57
Atorvastatin Calcium	Atorvastatin Calcium	348	87
Levothyroxine Sodium	Levothyroxine Sodium	306	66
Sertraline Hcl	Sertraline Hcl	279	67
Amlodipine Besylate	Amlodipine Besylate	231	59
Metoprolol Succinate	Metoprolol Succinate	216	40
Tamsulosin Hcl	Tamsulosin Hcl	197	42
Lisinopril	Lisinopril	193	40
Gabapentin	Gabapentin	177	54
Furosemide	Furosemide	175	44
Losartan Potassium	Losartan Potassium	162	34
Trazodone Hcl	Trazodone Hcl	142	32
Potassium Chloride	Potassium Chloride	141	41
Xarelto	Rivaroxaban	134	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	122	29
Pantoprazole Sodium	Pantoprazole Sodium	121	36
Clopidogrel	Clopidogrel Bisulfate	119	27
Metoprolol Tartrate	Metoprolol Tartrate	109	32
Donepezil Hcl	Donepezil Hcl	103	26
Jardiance	Empagliflozin	98	15
Memantine Hcl	Memantine Hcl	95	19
Tramadol Hcl	Tramadol Hcl	92	19
Famotidine	Famotidine	87	23
Metformin Hcl	Metformin Hcl	87	25
Mirtazapine	Mirtazapine	85	21
Divalproex Sodium	Divalproex Sodium	81	24
Levetiracetam	Levetiracetam	81	20
Omeprazole	Omeprazole	81	33
Spironolactone	Spironolactone	75	23
Risperidone	Risperidone	74	18
Escitalopram Oxalate	Escitalopram Oxalate	73	20
Allopurinol	Allopurinol	70	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	69	29
Entresto	Sacubitril/Valsartan	68	suppressed
Carvedilol	Carvedilol	66	22
Isosorbide Mononitrate Er	Isosorbide Mononitrate	66	13
Hydrochlorothiazide	Hydrochlorothiazide	65	12
Olanzapine	Olanzapine	65	14
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	56	26
Hydralazine Hcl	Hydralazine Hcl	55	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	55	11
Atenolol	Atenolol	53	suppressed
Lactulose	Lactulose	52	suppressed
Pregabalin	Pregabalin	52	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	49	18
Buspirone Hcl	Buspirone Hcl	48	17
Quetiapine Fumarate	Quetiapine Fumarate	47	15
Latanoprost	Latanoprost	46	13
Albuterol Sulfate Hfa	Albuterol Sulfate	44	25
Arexvy	Rsvpref3 Antigen/As01e/Pf	44	43
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	42	24
Brimonidine Tartrate	Brimonidine Tartrate	41	suppressed
Lorazepam	Lorazepam	41	12
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	41	suppressed
Digoxin	Digoxin	40	suppressed
Myrbetriq	Mirabegron	40	suppressed
Sodium Chloride	0.9 % Sodium Chloride	40	suppressed
Nystatin	Nystatin	39	23
Topiramate	Topiramate	38	suppressed
Duloxetine Hcl	Duloxetine Hcl	37	12
Bumetanide	Bumetanide	36	13
Ondansetron Odt	Ondansetron	35	14
Ropinirole Hcl	Ropinirole Hcl	35	12
Simvastatin	Simvastatin	35	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	34	suppressed
Cephalexin	Cephalexin	33	18
Warfarin Sodium	Warfarin Sodium	33	suppressed
Baclofen	Baclofen	32	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Prednisone	Prednisone	32	11
Ertapenem	Ertapenem Sodium	31	suppressed
Incruse Ellipta	Umeclidinium Bromide	31	suppressed
Rebif	Interferon Beta-1a/Albumin	28	suppressed
Amiodarone Hcl	Amiodarone Hcl	27	suppressed
Metformin Hcl Er	Metformin Hcl	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	17
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Torsemide	Torsemide	27	13
Fluticasone Propionate	Fluticasone Propionate	26	12
Metolazone	Metolazone	26	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	12
Diltiazem 24hr Er	Diltiazem Hcl	25	suppressed
Novolog Flexpen	Insulin Aspart	25	11
Vascepa	Icosapent Ethyl	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	19
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	24	17
Vancomycin Hcl	Vancomycin Hcl	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	22	suppressed
Multaq	Dronedarone Hcl	22	suppressed
Galantamine Hbr	Galantamine Hbr	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Insulin Aspart Flexpen	Insulin Aspart	20	12
Meloxicam	Meloxicam	20	suppressed
Lacosamide	Lacosamide	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Ozempic	Semaglutide	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Xifaxan	Rifaximin	19	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	18	suppressed
Lidocaine	Lidocaine	18	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Finasteride	Finasteride	17	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Lidocaine Hcl	Lidocaine Hcl	17	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	suppressed
Trintellix	Vortioxetine Hydrobromide	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Fentanyl	Fentanyl	16	suppressed
Levemir Flexpen	Insulin Detemir	16	suppressed
Primidone	Primidone	16	suppressed
Dexlansoprazole Dr	Dexlansoprazole	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Levofloxacin	Levofloxacin	15	suppressed
Linzess	Linaclotide	15	suppressed
Phenytoin	Phenytoin	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Retacrit	Epoetin Alfa-Epbx	14	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Nitroglycerin	Nitroglycerin	13	11
Sucralfate	Sucralfate	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Ceftriaxone	Ceftriaxone Sodium	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	12	suppressed
Verapamil Hcl	Verapamil Hcl	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Benztropine Mesylate	Benztropine Mesylate	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Clozapine	Clozapine	11	suppressed
Hydroxyurea	Hydroxyurea	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error